Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 17, 2023
Be The Match BioTherapies® announced it is offering CIBMTR® (Center for International Blood and Marrow Transplant Research) Clinical Research Organization Services (CRO Services), which allows sponsors to significantly reduce the time required to ...
read more
Tuesday, January 17, 2023
Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics announces that AVA6000 continues to show a very favourable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation ...
read more
Tuesday, January 10, 2023
Novotech an Asia Pacific centered biotech CRO announced the acquisition of CBR International, a global product development, clinical oversight and strategic regulatory operations group.
read more
Tuesday, January 10, 2023
Premier Research and Centogene N.V. have announced a strategic partnership to provide end-to-end support in rare disease clinical trials. The collaboration aims to improve patient identification, stratification, recruitment, and enrollment, thereby ...
read more
Thursday, January 05, 2023
Biognosys AG and Bruker Corporation announced a strategic partnership, in which Bruker has made a majority-ownership investment in Biognosys. Financial details were not disclosed.
read more
Friday, December 16, 2022
Syneos Health® announced it has extended its strategic partnership with Medable as part of the Company’s commitment to bring clinical trials closer to the patient.
read more
Monday, December 05, 2022
PHASTAR has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.
read more
Monday, December 05, 2022
Worldwide Clinical Trials has announced the appointment of Pete Duprat as Senior Vice President, Commercial, Early Phase. Duprat will lead business development and commercial activities for the CRO’s Early Phase business unit, consisting of its ...
read more
Monday, December 05, 2022
Founded in 2002, Brightech specializes in complex, value-add biostatistics, programming and clinical data management services. Similar to Everest, Brightech has earned a highly-regarded reputation as a critical partner for some of the world’s largest...
read more
Friday, December 02, 2022
Catalent announced that it has completed the expansion of its clinical supply facility in the Waigaoqiao Free Trade Zone (FTZ) in Shanghai, China.
read more
Thursday, December 01, 2022
As part of the Decentralized Trials and Research Alliance’s (DTRA) TGIF-DCT podcast series, global MedTech and patient servicing provider mdgroup join global clinical trial laboratory Q2 Solutions to explain how uniting vendors and service providers ...
read more
Tuesday, November 15, 2022
NorthStar Medical Radioisotopes announced a significant expansion of its business platform with the formation of a new, patient-focused Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) services unit.
read more
Friday, November 04, 2022
Exelixis, Inc. and Catalent, Inc. announced a new license agreement under which Catalent’s Redwood Bioscience subsidiary will grant Exelixis an exclusive license to three target programs with lead antibody and/or ADC candidates.
read more
Friday, November 04, 2022
QIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN, announced the launch of their new cell line database developed through its partnership with ATCC, a biological materials organization, developer and supplier of authenticated cell ...
read more
Wednesday, November 02, 2022
First Wave BioPharma, Inc. announced that it has entered into an agreement with Rho, a full-service contract research organization (CRO), for its planned Phase 2 clinical trial of an enhanced enteric microgranule delivery formulation for adrulipase.
read more